• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “U.S. Contraceptives Drugs and Devices Market – 2019-2024” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the U.S market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current Product Type and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the U.S. Contraceptives Drugs and Devices Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in U.S. Contraceptives Drugs and Devices Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

U.S. Contraceptives Drugs and Devices Market Size & Forecast:

U.S. Contraceptives Drugs and Devices market witnessed a market value of USD XX Million in 2019 and is estimated to reach USD XX million in 2024, registering a compound annual growth rate (CAGR) of XX% between 2019 and 2024.

U.S. Contraceptives Drugs and Devices Market Segmentation:-
The research offers a comprehensive analysis of U.S. Contraceptives Drugs and Devices market with respect to following sub-markets:

Based on Product Type:
- Contraceptive Drugs
- - - Oral Contraceptive Pills
- - - Contraceptive Injectables
- - - Topical Contraceptives
- Contraceptive Devices
- - - Male Contraceptive Devices
- - - - - Condoms
- Female Contraceptive Devices
- - - Female Condoms
- - - Contraceptive Diaphragms
- - - Contraceptive Sponges
- - - Contraceptive Vaginal Rings
- - - Intrauterine Devices
- - - - - Hormonal
- - - - - Copper-T
- - - Subdermal Contraceptive Implants

U.S. Contraceptives Drugs and Devices Market: Competitive Landscape

The report also highlights the competitive landscape of the U.S. Contraceptives Drugs and Devices market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Technology development, research & development and other market activities).

The report includes profiles of leading companies in the U.S. Contraceptives Drugs and Devices market.

Some of the key players profiled include:

- Teva Pharmaceutical Industries Ltd.
- Church & Dwight Co. Inc.
- Reckitt Benckiser Plc
- Pfizer, Inc.
- Bayer AG
- Mayer Laboratories, Inc.
- The Female Health Company
- Cooper Surgical, Inc.
- Allergan Plc
- Cipla Limited
- Merck & Co. Inc.
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2015 to 2017 – Historical Year
- 2018 – Base Year
- 2019 – Estimated Year
- 2019 to 2024 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the U.S. Contraceptives Drugs and Devices Industry Report:

- What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2019-2024?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Preface

1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process and Design
1.1.2.1. Secondary Research
1.1.2.2. Key Sources and Use of Primary Research
1.1.2.3. Market Size Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of the Study
1.5. Assumptions and Limitations for Market Estimation and Forecasting

2. Executive Summary

2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top U.S. Contraceptives Drugs and Devices Market Trends for 2019

3. Porter’s Five Force Analysis

3.1. Threat of Substitutes
3.2. Bargaining Power of Buyers
3.3. Bargaining Power of Suppliers
3.4. Threat of New Entrants
3.5. Degree of Competition

4. Manufacturing Cost Structure Analysis

4.1. Raw Material and Suppliers
4.2. Industry Chain Structure of U.S. Contraceptives Drugs and Devices Market
4.3. Manufacturing Process Analysis of U.S. Contraceptives Drugs and Devices Market
4.4. Manufacturing Cost Structure Analysis of U.S. Contraceptives Drugs and Devices Market

5. Manufacturing Plants Analysis of U.S. Contraceptives Drugs and Devices Market

5.1. Capacity and Production
5.2. U.S. Contraceptives Drugs and Devices Market Manufacturing Plants Distribution
5.3. Recent Development and Expansion Plans

6. Competitive Landscape

6.1. U.S. Contraceptives Drugs and Devices Market 2019
6.2. U.S. Contraceptives Drugs and Devices Market Value Share, By Company 2019
6.3. U.S. Contraceptives Drugs and Devices Market Volume Share, By Company 2019

7. Market Dynamics

7.1. Growth Drivers & Barriers in U.S. Contraceptives Drugs and Devices Market
7.2. Opportunities in U.S. Contraceptives Drugs and Devices Market

8. U.S. Contraceptives Drugs and Devices Market

8.1. Introduction
8.2. Key Trends & Growth Drivers
8.3. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

9. U.S. Contraceptives Drugs and Devices Market Segmentation Analysis, By Product Type

9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Product Type
9.2.2. Market Attractiveness, By Product Type
9.3. Contraceptive Drugs
9.3.1. Oral Contraceptive Pills
9.3.1.1. Key Trends & Growth Drivers
9.3.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.2. Contraceptive Injectables
9.3.2.1. Key Trends & Growth Drivers
9.3.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Topical Contraceptives
9.3.3.1. Key Trends & Growth Drivers
9.3.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Contraceptive Devices
9.4.1. Male Contraceptive Devices (Condoms)
9.4.1.1. Key Trends & Growth Drivers
9.4.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2. Female Contraceptive Devices
9.4.2.1. Female Condoms
9.4.2.1.1. Key Trends & Growth Drivers
9.4.2.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.2. Contraceptive Diaphragms
9.4.2.2.1. Key Trends & Growth Drivers
9.4.2.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.3. Contraceptive Sponges
9.4.2.3.1. Key Trends & Growth Drivers
9.4.2.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.4. Contraceptive Vaginal Rings
9.4.2.4.1. Key Trends & Growth Drivers
9.4.2.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.5. Intrauterine Devices (Hormonal & Copper-T)
9.4.2.5.1. Key Trends & Growth Drivers
9.4.2.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.6. Subdermal Contraceptive Implants
9.4.2.6.1. Key Trends & Growth Drivers
9.4.2.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.2.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

10. Company Profile

10.1. Market Share of Key Players in U.S. Contraceptives Drugs and Devices Market
10.2. U.S. Contraceptives Drugs and Devices Market Company Analysis
10.2.1. Teva Pharmaceutical Industries Ltd.
10.2.1.1. Company Overview
10.2.1.2. Product Offered
10.2.1.3. Business Strategy
10.2.1.4. Financials
10.2.1.5. SWOT Analysis
10.2.1.6. Market Share Analysis
10.2.1.7. Key Achievements & Developments
10.2.2. Church & Dwight Co. Inc.
10.2.2.1. Company Overview
10.2.2.2. Product Offered
10.2.2.3. Business Strategy
10.2.2.4. Financials
10.2.2.5. SWOT Analysis
10.2.2.6. Market Share Analysis
10.2.2.7. Key Achievements & Developments
10.2.3. Reckitt Benckiser Plc
10.2.3.1. Company Overview
10.2.3.2. Product Offered
10.2.3.3. Business Strategy
10.2.3.4. Financials
10.2.3.5. SWOT Analysis
10.2.3.6. Market Share Analysis
10.2.3.7. Key Achievements & Developments
10.2.4. Pfizer, Inc.
10.2.4.1. Company Overview
10.2.4.2. Product Offered
10.2.4.3. Business Strategy
10.2.4.4. Financials
10.2.4.5. SWOT Analysis
10.2.4.6. Market Share Analysis
10.2.4.7. Key Achievements & Developments
10.2.5. Bayer AG
10.2.5.1. Company Overview
10.2.5.2. Product Offered
10.2.5.3. Business Strategy
10.2.5.4. Financials
10.2.5.5. SWOT Analysis
10.2.5.6. Market Share Analysis
10.2.5.7. Key Achievements & Developments
10.2.6. Mayer Laboratories, Inc.
10.2.6.1. Company Overview
10.2.6.2. Product Offered
10.2.6.3. Business Strategy
10.2.6.4. Financials
10.2.6.5. SWOT Analysis
10.2.6.6. Market Share Analysis
10.2.6.7. Key Achievements & Developments
10.2.7. The Female Health Company
10.2.7.1. Company Overview
10.2.7.2. Product Offered
10.2.7.3. Business Strategy
10.2.7.4. Financials
10.2.7.5. SWOT Analysis
10.2.7.6. Market Share Analysis
10.2.7.7. Key Achievements & Developments
10.2.8. Cooper Surgical, Inc.
10.2.8.1. Company Overview
10.2.8.2. Product Offered
10.2.8.3. Business Strategy
10.2.8.4. Financials
10.2.8.5. SWOT Analysis
10.2.8.6. Market Share Analysis
10.2.8.7. Key Achievements & Developments
10.2.9. Allergan Plc
10.2.9.1. Company Overview
10.2.9.2. Product Offered
10.2.9.3. Business Strategy
10.2.9.4. Financials
10.2.9.5. SWOT Analysis
10.2.9.6. Market Share Analysis
10.2.9.7. Key Achievements & Developments
10.2.10. Cipla Limited
10.2.10.1. Company Overview
10.2.10.2. Product Offered
10.2.10.3. Business Strategy
10.2.10.4. Financials
10.2.10.5. SWOT Analysis
10.2.10.6. Market Share Analysis
10.2.10.7. Key Achievements & Developments
10.2.11. Merck & Co. Inc.
10.2.11.1. Company Overview
10.2.11.2. Product Offered
10.2.11.3. Business Strategy
10.2.11.4. Financials
10.2.11.5. SWOT Analysis
10.2.11.6. Market Share Analysis
10.2.11.7. Key Achievements & Developments
10.2.12. Other Prominent Players

11. Disclaimer

Select License Type
  • Single User License $2850 USD
  • Multi-User License $3850 USD
  • Corporate User License $4850 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients